NDAORALTABLET
Approved
Jan 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Kenacort (triamcinolone) is a systemic corticosteroid oral tablet approved in 1958 for broad anti-inflammatory and immunosuppressive indications. It treats conditions ranging from diabetic macular edema and retinal disorders to rheumatoid arthritis, psoriasis, dermatologic conditions, and allergic rhinitis. The drug works by suppressing immune and inflammatory responses across multiple tissue types.
LOE Approaching
As LOE approaches, brand team focus shifts from growth to lifecycle management and defending market share against newer mechanism competitors in ophthalmology, rheumatology, and dermatology segments.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Triamcinolone Ketorolac (TriKe) Knee Trial
Started Sep 2022
150 enrolled
Osteoarthritis, Knee
Triamcinolone Packing Following Endoscopic Sinus Surgery
Started Jan 2021
22 enrolled
Sinusitis
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Started Oct 2020
40 enrolled
Drug-Drug Interaction
Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Started Sep 2020
231 enrolled
Osteoarthritis, Knee
Kybella With Triamcinolone
Started Mar 2018
30 enrolled
Adiposity
Worked on KENACORT at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.